Modified Wheat Starch Resistant Starch Amylose Content
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Wheat starch composition does not readily allow for the production of high levels of resistant starch, which is beneficial for bowel health and metabolic health, due to its hexaploid genome structure and limited genetic variation, making it challenging to enhance its amylose content and resistant starch properties compared to other cereals like maize and rice.
Innovation Solution
Modifying the wheat plant to alter the activity and expression of starch biosynthetic enzymes such as starch synthase IIa and starch branching enzymes, specifically reducing the activity of SBEIIa and SBEIIb, to increase the amylose content in wheat starch to at least 30%, thereby increasing the levels of resistant starch and reducing the glycemic index.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If wheat is used as a staple food with its natural starch composition, then it provides good digestive properties and is easily processed, but it does not produce high levels of resistant starch and has limited genetic variation for improvement
Solution Approach 1:
The patent applies parameter changes by modifying the starch composition parameters of wheat through selective breeding and genetic modification. Specifically, the amylose content is increased from the natural ~30% to higher levels (40-70%), and the amylopectin structure is altered by modifying branching enzyme activity. These parameter changes enable the wheat starch to achieve resistant starch levels comparable to or exceeding traditional high-resistant-starch cereals like barley and rice, while maintaining wheat's processing advantages.
2Reliability
If the amylose content in wheat starch is increased to improve bowel health, then resistant starch levels increase and glycemic index decreases, but the starch structure becomes more complex and harder to control
Solution Approach 1:
The patent applies local quality by making targeted modifications to specific regions of the starch molecule rather than uniformly altering the entire starch structure. By modifying the branching enzyme (SBEIIa and SBEIIb) to reduce branching activity, the invention creates localized changes in the amylopectin structure (reducing branch points) while preserving the overall starch granule architecture and crystallinity. This allows increased amylose content and improved bowel health benefits without creating unmanageable structural complexity throughout the entire starch matrix.
3Quantity of substance
If starch branching enzyme activity is reduced to increase amylose content, then resistant starch increases and glycemic index decreases, but the starch synthesis process becomes less efficient
Solution Approach 1:
The patent applies partial action by selectively reducing the activity of specific branching enzymes (SBEIIa and SBEIIb) rather than completely eliminating branching activity or altering all starch synthesis enzymes. This partial reduction is sufficient to shift the starch composition toward higher amylose content (40-70%) and improved resistant starch levels, while maintaining enough branching enzyme function to ensure adequate starch synthesis efficiency and grain filling. The selective approach achieves the desired health benefits without causing excessive disruption to starch production productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified wheat starch improves bowel health by increasing resistant starch levels and lowering glycemic index, providing health benefits such as improved fecal bulk, increased short-chain fatty acid production, and enhanced metabolic health indicators like reduced insulin response and improved blood lipid profiles.
Implementation Method 1
This fraction is resistant starch (RS) which, together with a variable fraction of NSP, is metabolised by the large bowel microflora (Topping & Clifton, 2001). Short chain fatty acids (SCFA) are major end products of this fermentation
Implementation Method 2
The synthesis of starch in the endosperm of higher plants is carried out by a suite of enzymes that catalyse four key steps. Firstly, ADP-glucose pyrophosphorylase activates the monomer precursor of starch through the synthesis of ADP-glucose from G-1-P and ATP
Data Source
AI summary
A method and composition for improving one or more indicators of bowel health or metabolic health in a mammalian animal. This comprises the delivering to the gastrointestinal tract of the animal an effective amount of an altered wheat starch in the form of or derived from the grain of a wheat plant. The proportion of amylose in the starch of the grain is at least 30%.